Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer
about
Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapyProteomic-Based Approaches for the Study of Cytokines in Lung CancerMolecular and Cellular Effects of Hydrogen Peroxide on Human Lung Cancer Cells: Potential Therapeutic ImplicationsBiomarkers of risk to develop lung cancer in the new screening eraLung cancer in HIV-infected patients in the combination antiretroviral treatment eraLung cancer: a classic example of tumor escape and progression while providing opportunities for immunological interventionHIV infection, aging, and immune function: implications for cancer risk and preventionThe CXCL8-CXCR1/2 pathways in cancerThe NLRP3 inflammasome in pathogenic particle and fibre-associated lung inflammation and diseasesPromotion of a cancer-like phenotype, through chronic exposure to inflammatory cytokines and hypoxia in a bronchial epithelial cell line modelA Highly Efficient Gene Expression Programming (GEP) Model for Auxiliary Diagnosis of Small Cell Lung CancerSingle nucleotide polymorphisms as susceptibility, prognostic, and therapeutic markers of nonsmall cell lung cancerA multiplexed serum biomarker immunoassay panel discriminates clinical lung cancer patients from high-risk individuals found to be cancer-free by CT screeningPredicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkersEpithelial-mesenchymal transition in cancer: Role of the IL-8/IL-8R axis.Immune profiles and clinical outcomes between sepsis patients with or without active cancer requiring admission to intensive care unitsValidation of a blood protein signature for non-small cell lung cancerA review of the application of inflammatory biomarkers in epidemiologic cancer research.Helicobacter pylori seropositivity and risk of lung cancer.C-reactive protein, interleukin 6 and lung cancer risk: a meta-analysisInflammation and oxidative stress markers and esophageal adenocarcinoma incidence in a Barrett's esophagus cohort.Depletion of tumor-associated macrophages slows the growth of chemically induced mouse lung adenocarcinomasA combined prognostic serum interleukin-8 and interleukin-6 classifier for stage 1 lung cancer in the prostate, lung, colorectal, and ovarian cancer screening trialThe effect of lung cancer on cytokine expression in peripheral blood mononuclear cellsPrediagnostic serum levels of inflammatory biomarkers are correlated with future development of lung and esophageal cancer.Identification of a functional SNP in the 3'UTR of CXCR2 that is associated with reduced risk of lung cancer.Urinary protein biomarkers in the early detection of lung cancer.Association between C-reactive protein, incident liver cancer, and chronic liver disease mortality in the Linxian Nutrition Intervention Trials: a nested case-control study.Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer.Comparative impact of antiretroviral drugs on markers of inflammation and immune activation during the first two years of effective therapy for HIV-1 infection: an observational study.Correlations Between Serum IL-6 Levels and Radiation Pneumonitis in Lung Cancer Patients: A Meta-Analysis.Luteolin inhibits Cr(VI)-induced malignant cell transformation of human lung epithelial cells by targeting ROS mediated multiple cell signaling pathways.Factors associated with inflammation markers, a cross-sectional analysis.Curcumin regulates airway epithelial cell cytokine responses to the pollutant cadmiumPlasma C-reactive protein and risk of breast cancer in two prospective studies and a meta-analysis.Metabolic serum biomarkers for the prediction of cancer: a follow-up of the studies conducted in the Swedish AMORIS studyPrognostic Significance of Serum Inflammatory Response Markers in Newly Diagnosed Non-Small Cell Lung Cancer before ChemoirradiationA study on the effect of IL-6 gene polymorphism on the prognosis of non-small-cell lung cancer.As an independent unfavorable prognostic factor, IL-8 promotes metastasis of nasopharyngeal carcinoma through induction of epithelial-mesenchymal transition and activation of AKT signalingA peripheral circulating TH1 cytokine profile is inversely associated with prostate cancer risk in CLUE II.
P2860
Q24597964-0EB3E8DD-3430-4761-829C-B4C48573447AQ26738539-D351E11D-6865-4710-9F51-46884817A0A6Q26744815-354996D5-9261-4A3D-9ADB-6FBCFE3AE0C5Q26747784-B3EA7ADE-D688-4BFB-90D3-98161F50E3EBQ26769769-E683DF44-129D-4AA8-AF8C-3AFED3EE73BCQ26850218-711C04E6-354C-41D7-9B65-376548171C35Q27004165-8BF5FE9D-42B3-4FD2-920A-F3429F0D9408Q28075994-5895F88E-7C2A-4068-852C-17B81F54FD6BQ28080249-32DBD586-663D-4E26-A91A-8D6E740DBDEFQ28384920-68C3C718-9FDA-4AD3-B1C4-2392FAF2D300Q28547421-10F833D1-D1E7-49EE-9903-85F3CBC8D993Q28816916-55EEAEC3-F9C9-48B7-95A3-BFCCB481428AQ30511822-5D902200-6D13-494D-8F58-7B162F9EBD48Q33713347-852BE45A-D631-4A22-8B6B-96D5C5BBD42CQ33751266-63C718C9-3F26-414B-AB39-24093EF85151Q33888114-6F0A2CA2-86C1-4B73-9D19-9C37B0E4E9D7Q34008245-809336A5-4ED7-48D8-9C15-8F4CA5337E00Q34135803-6D4B3A90-2882-4D73-8899-EBB40E72DEB1Q34182270-8443C8D6-3F4A-4182-8F2D-E83D0252368BQ34389236-C0ACCF00-784B-4037-AE14-170223C9CD9FQ34457732-F165E7DB-B5AE-49FA-857F-65E5725D9933Q34569613-96EEA414-5DBF-4119-B485-734EA2AB4815Q34747013-AE5BA8C0-0C3B-4F73-A36D-5567987B367DQ34769405-14185F33-6164-4657-8E5B-631884311DC8Q35007052-8DC973BE-CB01-4DDB-9506-6A4BE6BDC07FQ35044351-443E5805-211C-411A-8520-2FEC48A7DC4DQ35044516-1C5912CF-72A2-4C38-9028-CEC38485E56BQ35071202-64D3C3E1-D172-4D00-A1DB-3CB17FE12D42Q35104929-0DEDD61E-C86B-4BC6-AB13-F4CD68BD1F19Q35109483-E01EA912-6BB3-4A7E-A846-6180A6CF1369Q35535045-E8BFA4D9-F6B9-4C10-ADC2-5DB77A9D9CD7Q35610268-D7068A65-AC3D-4604-A3D3-88621DE9E522Q35633792-73B1AFEF-4EFC-4D0A-B1C3-9DE791EFBB7FQ35675278-53DC5684-99B0-4C53-A9CB-73C038B40C2AQ35920877-7F2ABB73-89F3-4875-8DDB-BA628229D041Q35935362-2B1561BE-5D9B-43F8-9441-A04D7FD7B15FQ35960578-0ED192A0-57B6-4617-BE5B-2ADD87337B31Q36111795-941782FA-E06E-4716-A80E-F8B3F7DE714BQ36118892-0EF95262-CF13-467F-89B4-E6FBB8BA38A4Q36288241-CC54A038-B13F-4790-B22F-AEDE1C6E7370
P2860
Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Increased levels of circulatin ...... otein, and risk of lung cancer
@ast
Increased levels of circulatin ...... otein, and risk of lung cancer
@en
type
label
Increased levels of circulatin ...... otein, and risk of lung cancer
@ast
Increased levels of circulatin ...... otein, and risk of lung cancer
@en
prefLabel
Increased levels of circulatin ...... otein, and risk of lung cancer
@ast
Increased levels of circulatin ...... otein, and risk of lung cancer
@en
P2093
P2860
P356
P1476
Increased levels of circulatin ...... otein, and risk of lung cancer
@en
P2093
Anil K Chaturvedi
Curtis C Harris
Elise D Bowman
Eric A Engels
Hormuzd A Katki
Leah E Mechanic
Lindsey Enewold
Neil E Caporaso
Sharon R Pine
Yun-Ling Zheng
P2860
P304
P356
10.1093/JNCI/DJR216
P407
P577
2011-06-17T00:00:00Z